Alvogen CEO Robert Wessman speaks exclusively to World Finance about new opportunities in generic pharmaceuticals LONDON, Jan. 22, 2018 (GLOBE NEWSWIRE) -- Industry disruptor Robert Wessman, the CEO of rapidly growing generic pharmaceuticals company Alvogen, shares his thoughts on the latest market trends in...

A man on a mission to transform generic pharmaceuticals: Alvogen CEO and founder, Robert Wessman, discusses the company’s growth LONDON, Jan. 04, 2018 (GLOBE NEWSWIRE) -- The pharmaceuticals industry is going through one of its most exciting periods yet. Generic pharmaceuticals have taken off, leading to much more innovation...